Elliott Gruskin

Company: Azome Therapeutics

Job title: Chief Executive Officer

Seminars:

Fireside Chat: What Each Stakeholder Needs – Repositioning Inflammasome Therapies for Clinical, Commercial & Capital Success 4:00 pm

Exploring the rationale for advancing multiple inflammasome-targeting programs in parallel while managing clinical risk through indication diversity Outlining key regulatory requirements for inflammasome-targeting therapeutics (safety pharmacology, dosing windows, and MOA validation) Shedding light on how successful Phase II data influences Series B/C financing rounds, partnerships, and acquisition strategiesRead more

day: Conference Day One PM